Literature DB >> 3322783

Serous and recurrent otitis media. Pharmacological or surgical management?

C D Marchant1, L M Collison.   

Abstract

The management of recurrent acute otitis media and serous otitis media is both challenging and controversial. The efficacy of antimicrobial prophylaxis of children at high risk for recurrent acute otitis media is established, but the indications for such therapy are controversial. Tympanostomy tube insertion also decreases the frequency of recurrent otitis media. High-risk children can be successfully managed with chemoprophylaxis from autumn through to spring. If this fails, then tympanostomy tube insertion should be considered. Serous otitis media that follows acute otitis media resolves spontaneously in more than 90% of cases. Serous otitis media of unknown onset also has a strong tendency to resolve without treatment. Antihistamines and decongestants, although popular, have no significant effect on the course of serous otitis media. Antimicrobial therapy has a modest effect on the resolution of serous otitis media. Tympanostomy tubes usually improve the conductive hearing loss associated with serous otitis media and should be used when bilateral serous otitis media fails to resolve spontaneously. If repeated tympanostomy tube insertion fails, then adenoidectomy should be considered. With the course of management outlined, most children will have a successful outcome with conservative therapy and the need for surgery will be minimised.

Entities:  

Mesh:

Year:  1987        PMID: 3322783     DOI: 10.2165/00003495-198734060-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  10 in total

1.  Otoscopic, impedance, and audiometric findings in glue ear treated by adenoidectomy and tonsillectomy. A prospective randomised study.

Authors:  A R Maw; F Herod
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

2.  Sulfisoxazole as chemoprophylaxis for recurrent otitis media. A double-blind crossover study in pediatric practice.

Authors:  J M Perrin; E Charney; J B MacWhinney; T K McInerny; R L Miller; L F Nazarian
Journal:  N Engl J Med       Date:  1974-09-26       Impact factor: 91.245

3.  Treatment of chronic otitis media with effusion: results of tympanostomy tubes.

Authors:  G A Gates; C Wachtendorf; E M Hearne; G R Holt
Journal:  Am J Otolaryngol       Date:  1985 May-Jun       Impact factor: 1.808

4.  Course and outcome of otitis media in early infancy: a prospective study.

Authors:  C D Marchant; P A Shurin; V A Turczyk; D E Wasikowski; M A Tutihasi; S E Kinney
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

5.  Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children. Results of a double-blind, randomized trial.

Authors:  E M Mandel; H E Rockette; C D Bluestone; J L Paradise; R J Nozza
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

6.  Otitis media with effusion during the first three years of life and development of speech and language.

Authors:  D W Teele; J O Klein; B A Rosner
Journal:  Pediatrics       Date:  1984-08       Impact factor: 7.124

7.  Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. Results of a double-blind, randomized trial.

Authors:  E I Cantekin; E M Mandel; C D Bluestone; H E Rockette; J L Paradise; S E Stool; T J Fria; K D Rogers
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

8.  Tympanostomy tubes in the otitis media prone child.

Authors:  D E Gebhart
Journal:  Laryngoscope       Date:  1981-06       Impact factor: 3.325

9.  Oral dexamethasone for treatment of persistent middle ear effusion.

Authors:  M L Macknin; P K Jones
Journal:  Pediatrics       Date:  1985-02       Impact factor: 7.124

10.  Epidemiology of otitis media in children.

Authors:  D W Teele; J O Klein; B A Rosner
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1980 May-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.